dc.contributor.author | Tutka, Klaudia | |
dc.contributor.author | Żychowska, Magdalena | |
dc.contributor.author | Reich, Adam | |
dc.contributor.author | Żaczek, Anna | |
dc.contributor.author | Maternia-Dudzik, Karolina | |
dc.contributor.author | Pawełczyk, Jakub | |
dc.contributor.author | Strapagiel, Dominik | |
dc.contributor.author | Lach, Jakub | |
dc.date.accessioned | 2023-10-27T05:01:58Z | |
dc.date.available | 2023-10-27T05:01:58Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Tutka, K.; Zychowska, M.; ˙ Zaczek, A.; Maternia-Dudzik, K.; ˙ Pawełczyk, J.; Strapagiel, D.; Lach, J.; Reich, A. Skin Microbiome in Prurigo Nodularis. Int. J. Mol. Sci. 2023, 24, 7675. https://doi.org/10.3390/ ijms24087675 | pl_PL |
dc.identifier.issn | 1661-6596 | |
dc.identifier.uri | http://hdl.handle.net/11089/48203 | |
dc.description.abstract | Prurigo nodularis (PN) is a chronic condition characterized by the presence of nodular
lesions accompanied by intense pruritus. The disease has been linked to several infectious factors,
but data on the direct presence of microorganisms in the lesions of PN are scarce. The aim of this
study was to evaluate the diversity and composition of the bacterial microbiome in PN lesions by
targeting the region V3-V4 of 16S rRNA. Skin swabs were obtained from active nodules in 24 patients
with PN, inflammatory patches of 14 patients with atopic dermatitis (AD) and corresponding skin
areas of 9 healthy volunteers (HV). After DNA extraction, the V3-V4 region of the bacterial 16S
rRNA gene was amplified. Sequencing was performed using the Illumina platform on the MiSeq
instrument. Operational taxonomic units (OTU) were identified. The identification of taxa was
carried out using the Silva v.138 database. There was no statistically significant difference in the
alpha-diversity (intra-sample diversity) between the PN, AD and HV groups. The beta-diversity
(inter-sample diversity) showed statistically significant differences between the three groups on a
global level and in paired analyses. Staphylococcus was significantly more abundant in samples from
PN and AD patients than in controls. The difference was maintained across all taxonomic levels. The
PN microbiome is highly similar to that of AD. It remains unclear whether the disturbed composition
of the microbiome and the domination of Staphylococcus in PN lesions may be the trigger factor of
pruritus and lead to the development of cutaneous changes or is a secondary phenomenon. Our
preliminary results support the theory that the composition of the skin microbiome in PN is altered
and justify further research on the role of the microbiome in this debilitating condition. | pl_PL |
dc.description.sponsorship | This research was supported by the mini-Dgrant provided by the Polish Dermatological
Society to Dr. Magdalena Zychowska (1/2020). | pl_PL |
dc.language.iso | en | pl_PL |
dc.publisher | MDPI | pl_PL |
dc.relation.ispartofseries | International Journal of Molecular Sciences;24, 7675 | |
dc.rights | Uznanie autorstwa 4.0 Międzynarodowe | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | microbiome | pl_PL |
dc.subject | microbiota | pl_PL |
dc.subject | prurigo nodularis | pl_PL |
dc.subject | bacteria | pl_PL |
dc.subject | 16S rRNA | pl_PL |
dc.subject | DNA sequencing | pl_PL |
dc.title | Skin Microbiome in Prurigo Nodularis | pl_PL |
dc.type | Article | pl_PL |
dc.page.number | 18 | pl_PL |
dc.contributor.authorAffiliation | Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, 35-055 Rzeszów, Poland | pl_PL |
dc.contributor.authorAffiliation | Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, 35-055 Rzeszów, Poland | pl_PL |
dc.contributor.authorAffiliation | Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, 35-055 Rzeszów, Poland | pl_PL |
dc.contributor.authorAffiliation | Department of Microbiology, Institute of Medical Sciences, Medical College of Rzeszow University, 35-055 Rzeszów, Poland | pl_PL |
dc.contributor.authorAffiliation | Department of Microbiology, Institute of Medical Sciences, Medical College of Rzeszow University, 35-055 Rzeszów, Poland | pl_PL |
dc.contributor.authorAffiliation | Biobank Laboratory, Department of Oncobiology and Epigenetics, Faculty of Biology and Environmental Protection, University of Lodz, 90-235 Łódź, Poland | pl_PL |
dc.contributor.authorAffiliation | Biobank Laboratory, Department of Oncobiology and Epigenetics, Faculty of Biology and Environmental Protection, University of Lodz, 90-235 Łódź, Poland | pl_PL |
dc.identifier.eissn | 1422-0067 | |
dc.references | Pereira, M.P.; Steinke, S.; Zeidler, C.; Forner, C.; Riepe, C.; Augustin, M.; Bobko, S.; Dalgard, F.; Elberling, J.; Garcovich, S.; et al. European Academy of Dermatology and Venereology European prurigo project: Expert consensus on the definition, classification and terminology of chronic prurigo. J. Eur. Acad. Dermatol. Venereol. 2018, 32, 1059–1065. | pl_PL |
dc.references | Huang, A.H.; Williams, K.A.; Kwatra, S.G. Prurigo nodularis: Epidemiology and clinical features. J. Am. Acad. Dermatol. 2020, 83, 1559–1565. | pl_PL |
dc.references | Huang, A.H.; Canner, J.K.; Khanna, R.; Kang, S.; Kwatra, S.G. Real-world prevalence of prurigo nodularis and burden of associated diseases. J. Investig. Dermatol. 2020, 140, 480–483.e4. | pl_PL |
dc.references | Iking, A.; Grundmann, S.; Chatzigeorgakidis, E.; Phan, N.Q.; Klein, D.; Stander, S. Prurigo as a symptom of atopic and non-atopic diseases: Aetiological survey in a consecutive cohort of 108 patients. J. Eur. Acad. Dermatol. Venereol. 2013, 27, 550–557. | pl_PL |
dc.references | Schweda, K.; Hainz, M.; Loquai, C.; Grabbe, S.; Saloga, J.; Tuettenberg, A. Prurigo nodularis as index symptom of (non-Hodgkin) lymphoma: Ultrasound as a helpful diagnostic tool in dermatological disorders of unknown origin. Int. J. Dermatol. 2015, 54, 462–464. | pl_PL |
dc.references | Larson, V.A.; Tang, O.; Stander, S.; Miller, L.S.; Kang, S.; Kwatra, S. Association between prurigo nodularis and malignancy in middle-aged adults. J. Am. Acad. Dermatol. 2019, 81, 1198–1201. | pl_PL |
dc.references | Boozalis, E.; Tang, O.; Patel, S.; Semenov, Y.R.; Pereira, M.P.; Stander, S.; Kang, S.; Kwatra, S.G. Ethnic differences and comorbidities of 909 prurigo nodularis patients. J. Am. Acad. Dermatol. 2018, 79, 714–719.e3. | pl_PL |
dc.references | Tanaka, M.; Aiba, S.; Matsumura, N.; Aoyama, H.; Tagami, H. Prurigo nodularis consists of two distinct forms: Early-onset atopic and late-onset non-atopic. Dermatology 1995, 190, 269–276. | pl_PL |
dc.references | Williams, K.A.; Huang, A.H.; Belzberg, M.; Kwatra, S.G. Prurigo nodularis: Pathogenesis and management. J. Am. Acad. Dermatol. 2020, 83, 1567–1575. | pl_PL |
dc.references | Zeidler, C.; Yosipovitch, G.; Stander, S. Prurigo nodularis and its management. Dermatol. Clin. 2018, 36, 189–197. | pl_PL |
dc.references | Kwatra, S.G. Breaking the itch-scratch cycle in prurigo nodularis. N. Eng. J. Med. 2020, 382, 757–758. | pl_PL |
dc.references | Kaushik, S.B.; Cerci, F.B.; Miracle, J.; Pokharel, A.; Chen, S.C.; Chan, Y.H.; Wilkin, A.; Yosipovitch, G. Chronic pruritus in HIV-positive patients in the southeastern United States: Its prevalence and effect on quality of life. J. Am. Acad. Dermatol. 2014, 70, 659–664. | pl_PL |
dc.references | Magand, F.; Nacher, M.; Cazorla, C.; Cambazard, F.; Marie, D.S.; Couppie, P. Predictive values of prurigo nodularis and herpes zster for HIV infection and immunosuppression requiring HAART in French Guiana. Trans. R. Soc. Trop. Med. Hyg. 2011, 105, 401–404. | pl_PL |
dc.references | Motegi, S.; Kato, M.; Uchiyama, A.; Yamada, K.; Shimizu, A.; Amano, H.; Ishikawa, O. Persistent prurigo nodularis in HIV-infected patient responsive to antiretrivural therapy with raltegravir. J. Dermatol. 2014, 41, 272–273. | pl_PL |
dc.references | Unemori, P.; Leslie, K.; Maurer, T. Persistent prurigo nodularis responsive to initiation of combination therapy with raltegravir. Arch. Dermatol. 2010, 146, 682–683. | pl_PL |
dc.references | Weisshaar, E.; Stander, S. Prurigo nodularis in hepatitis C infection: Result of an occupational disease? Acta Derm. Venereol. 2012, 92, 532–533. | pl_PL |
dc.references | Kanazawa, K.; Yaoita, H.; Tsuda, F.; Murata, K.; Okamoto, H. Association of prurigo with hepatitis C virus infection. Arch. Dermatol. 1995, 131, 852–853. | pl_PL |
dc.references | Mattila, J.O.; Vornanen, M.; Katila, M.L. Histopathological and bacteriological findings in prurigo nodularis. Acta Derm. Venereol. 1997, 77, 49–51. | pl_PL |
dc.references | Saporito, L.; Floren, A.M.; Colomba, C.; Pampinella, D.; Di Carlo, P. Prurigo nodularis due to Mycobacterium tuberculosis. J. Med. Microbiol. 2009, 58, 1649–1651. | pl_PL |
dc.references | Sharma, A.D. Oral ketotifen and topical antibiotic therapy in the management of pruritus in prurigo nodularis: A randomized, controlled, single-blind, parallel study. Indian. J. Dermatol. 2013, 58, 355–359. | pl_PL |
dc.references | Fyhrquist, N.; Muirhead, G.; Prast-Nielsen, S.; Jeanmougin, M.; Olah, P.; Skoog, T.; Jules-Clement, G.; Feld, M.; BarrientosSomarribas, M.; Sinkko, H.; et al. Microbe-host interplay in atopic dermatitis and psoriasis. Nat. Commun. 2019, 10, 4703. | pl_PL |
dc.references | Bay, L.; Barnes, C.J.; Fritz, B.G.; Thorsen, J.; Restrup, M.E.M.; Rasmussen, L.; Sørensen, J.K.; Hesselvig, A.B.; Odgaard, A.; Hansen, A.J.; et al. Universal Dermal Microbiome in Human Skin. mBio 2020, 11, e02945-19. | pl_PL |
dc.references | Ahle, C.M.; Stødkilde, K.; Afshar, M.; Poehlein, A.; Ogilvie, L.A.; Söderquist, B.; Hüpeden, J.; Brüggemann, H. Staphylococcus saccharolyticus: An Overlooked Human Skin Colonizer. Microorganisms 2020, 8, 1105. | pl_PL |
dc.references | Byrd, A.L.; Belkaid, Y.; Segre, J.A. The human skin microbiome. Nat. Rev. Microbiol. 2018, 16, 143–155. | pl_PL |
dc.references | Dickson, R.P.; Erb-Downward, J.R.; Prescott, H.C.; Martinez, F.J.; Curtis, J.L.; Lama, V.N.; Huffnagle, G.B. Analysis of culturedependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid. J. Clin. Microbiol. 2014, 52, 3605–3613. | pl_PL |
dc.references | Cogen, A.L.; Nizet, V.; Gallo, R.L. Skin microbiota: A source of disease or defence? Br. J. Dermatol. 2008, 158, 442–455. | pl_PL |
dc.references | Tutka, K.; Zychowska, M.; Reich, A. Diversity and composition of the skin, blood and gut microbiome in rosacea—A systematic review of the literature. Microorganisms 2020, 8, 1756. | pl_PL |
dc.references | Ma ´nkowska-Wierzbicka, D.; Karczewski, J.; Dobrowolska-Zachwieja, A.; Adamski, Z. The microbiome and dermatologicaldiseases. Adv. Hyg. Exp. Med. 2015, 69, 978–985. | pl_PL |
dc.references | Schmid, B.; Küstner, A.; Fähnrich, A.; Bersuch, E.; Schmid-Grendelmeier, P.; Busch, H.; Glatz, M.; Bosshard, P.P. Dysbiosis of skin microbiota with increased fungal diversity is associated with severity of disease in atopic dermatitis. J. Eur. Acad. Dermatol. Venereol. 2022, 36, 1811–1819. | pl_PL |
dc.references | Edslev, S.M.; Olesen, C.M.; Nørreslet, L.B.; Ingham, A.C.; Iversen, S.; Lilje, B.; Clausen, M.L.; Jensen, J.S.; Stegger, M.; Agner, T.; et al. Staphylococcal communities on skin are associated with atopic dermatitis and disease severity. Microorganisms 2021, 9, 432. | pl_PL |
dc.references | Totté, J.E.E.; Pardo, L.M.; Fieten, K.B.; Vos, M.C.; van den Broek, T.J.; Schuren, F.H.J.; Pasmans, S.G.M.A. Nasal and skin microbiomes are associated with disease severity in paediatric atopic dermatitis. Br. J. Dermatol. 2019, 181, 796–806. | pl_PL |
dc.references | Cao, P.; Xu, W.; Jiang, S.; Zhang, L. Dupilumab for the treatment of prurigo nodularis: A systematic review. Front. Immunol. 2023, 14, 1092685. | pl_PL |
dc.references | Grice, E.A.; Segre, J.A. The skin microbiome. Nat. Rev. Microbiol. 2011, 9, 244–253. | pl_PL |
dc.references | Zollner, T.M.; Wichelhaus, T.A.; Hartung, A.; Von Mallinckrodt, C.; Wagner, T.O.; Brade, V.; Kaufmann, R. Colonization with superantigen-producing Stphylococcus aureus is associated with increased severity of atopic dermatitis. Clin. Exp. Allergy 2000, 30, 994–1000. | pl_PL |
dc.references | Dinges, M.M.; Orwin, P.M.; Schlievert, P.M. Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev. 2000, 13, 16–34. | pl_PL |
dc.references | Hong, S.W.; Choi, E.B.; Min, T.K.; Kim, J.H.; Kim, M.H.; Jeon, S.G.; Lee, B.J.; Gho, Y.S.; Jee, Y.K.; Pyun, B.Y.; et al. An important role of α-hemolysin in extracellular vesicles on the development of atopic dermatitis induced by Staphylococcus aureus. PLoS ONE 2014, 9, e100499. | pl_PL |
dc.references | Nakamura, Y.; Oscherwitz, J.; Cease, K.B.; Chan, S.M.; Muñoz-Planillo, R.; Hasegawa, M.; Villaruz, A.E.; Cheung, G.Y.; McGavin, M.J.; Travers, J.B.; et al. Staphylococcus δ-toxin induces allergic skin disease by activating mast cells. Nature 2013, 503, 397–401. | pl_PL |
dc.references | Chung, E.J.; Luo, C.H.; Thio, C.L.; Chang, Y.J. Immunomodulatory Role of Staphylococcus aureus in Atopic Dermatitis. Pathogens 2022, 11, 422. | pl_PL |
dc.references | Periasamy, S.; Chatterjee, S.S.; Cheung, G.Y.; Otto, M. Phenol-soluble modulins in staphylococci: What are they originally for? Commun. Integr. Biol. 2012, 5, 275–277. | pl_PL |
dc.references | Damour, A.; Robin, B.; Deroche, L.; Broutin, L.; Bellin, N.; Verdon, J.; Lina, G.; Leclère, F.M.; Garcia, M.; Cremniter, J.; et al. Phenol-soluble modulins α are major virulence factors of Staphylococcus aureus secretome promoting inflammatory response in human epidermis. Virulence 2021, 12, 2474–2492. | pl_PL |
dc.references | Marschall, P.; Wei, R.; Segaud, J.; Yao, W.; Hener, P.; German, B.F.; Meyer, P.; Hugel, C.; Da Silva, G.A.; Braun, R.; et al. Dual function of Langerhans cells in skin TSLP-promoted TFH differentiation in mouse atopic dermatitis. J. Allergy Clin. Immunol. 2021, 147, 1778–1794. | pl_PL |
dc.references | Indra, A.K. Epidermal TSLP: A trigger factor for pathogenesis of atopic dermatitis. Expert. Rev. Proteom. 2013, 10, 309–311. | pl_PL |
dc.references | Grimstad, O.; Sawanobori, Y.; Vestergaard, C.; Bilsborough, J.; Olsen, U.B.; Grønhøj-Larsen, C.; Matsushima, K. Anti-interleukin31-antibodies ameliorate scratching behaviour in NC/Nga mice: A model of atopic dermatitis. Exp. Dermatol. 2009, 18, 35–43. | pl_PL |
dc.references | Beck, L.A.; Cork, M.J.; Amagai, M.; De Benedetto, A.; Kabashima, K.; Hamilton, J.D.; Rossi, A.B. Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis. JID Innov. 2022, 2, 100131. | pl_PL |
dc.references | Huse, S.M.; Ye, Y.; Zhou, Y.; Fodor, A.A. A core human microbiome as viewed through 16S rRNA sequence clusters. PLoS ONE 2012, 7, e34242. | pl_PL |
dc.references | Ständer, S.; Pereira, M.P.; Berger, T.; Zeidler, C.; Augustin, M.; Bobko, S.; Brenaut, E.; Chen, S.C.; Chisolm, S.; Dalgard, F.; et al. IFSI-guideline on chronic prurigo including prurigo nodularis. Itch 2020, 5, e42. | pl_PL |
dc.references | Bolyen, E.; Rideout, J.R.; Dillon, M.R.; Bokulich, N.A.; Abnet, C.C.; Al-Ghalith, G.A.; Alexander, H.; Alm, E.J.; Arumugam, M.; Asnicar, F.; et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 2019, 37, 852–857. | pl_PL |
dc.references | Mandal, S.; Van Treuren, W.; White, R.A.; Eggesbø, M.; Knight, R.; Peddada, S.D. Analysis of composition of microbiomes: A novel method for studying microbial composition. Microb. Ecol. Health Dis. 2015, 26, 27663. | pl_PL |
dc.identifier.doi | 10.3390/ ijms24087675 | |
dc.discipline | nauki biologiczne | pl_PL |